Literature DB >> 15909151

[Skin changes with chemotherapy].

A L Branzan1, M Landthaler, R-M Szeimies.   

Abstract

Skin changes in cancer patients have many causes and are difficult to categorize. Chemotherapy-associated cutaneous side effects are usually toxic and often show a characteristic reaction pattern, offering diagnostic clues to the consulting dermatologist. Severe chemotherapy-associated reactions which require dose reduction, change or discontinuation of the cytostatic agents are rare. Most problems are reversible and self-limiting disease. The most common chemotherapy reactions are reviewed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15909151     DOI: 10.1007/s00105-005-0971-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  40 in total

1.  Chemotherapy-induced onycholysis.

Authors:  A Makris; P Mortimer; T J Powles
Journal:  Eur J Cancer       Date:  1996-02       Impact factor: 9.162

Review 2.  Disorders of hyperpigmentation.

Authors:  A G Pandya; I L Guevara
Journal:  Dermatol Clin       Date:  2000-01       Impact factor: 3.478

Review 3.  Cutaneous reactions to chemotherapeutic agents.

Authors:  R A Koppel; E E Boh
Journal:  Am J Med Sci       Date:  2001-05       Impact factor: 2.378

Review 4.  Management of chemotherapy-induced nausea, vomiting, oral mucositis, and diarrhoea.

Authors:  Rohini Sharma; Peter Tobin; Stephen J Clarke
Journal:  Lancet Oncol       Date:  2005-02       Impact factor: 41.316

5.  [Eccrine hidradenitis. Case report and review of the literature].

Authors:  A Okcu; H P Soyer; S Kaddu; H Lackner; E Aberer
Journal:  Hautarzt       Date:  1997-10       Impact factor: 0.751

Review 6.  Antineoplastic therapy-induced palmar plantar erythrodysesthesia ('hand-foot') syndrome. Incidence, recognition and management.

Authors:  E Nagore; A Insa; O Sanmartín
Journal:  Am J Clin Dermatol       Date:  2000 Jul-Aug       Impact factor: 7.403

7.  Inflammation of actinic keratoses from systemic chemotherapy.

Authors:  T M Johnson; R P Rapini; M Duvic
Journal:  J Am Acad Dermatol       Date:  1987-08       Impact factor: 11.527

Review 8.  Sweet's syndrome (acute febrile neutrophilic dermatosis)

Authors:  P von den Driesch
Journal:  J Am Acad Dermatol       Date:  1994-10       Impact factor: 11.527

9.  [Linear hyperpigmentation caused by bleomycin].

Authors:  J Albig; H Gollnick; M Detmar; C E Orfanos
Journal:  Hautarzt       Date:  1992-06       Impact factor: 0.751

10.  Hypersensitivity reactions from taxol.

Authors:  R B Weiss; R C Donehower; P H Wiernik; T Ohnuma; R J Gralla; D L Trump; J R Baker; D A Van Echo; D D Von Hoff; B Leyland-Jones
Journal:  J Clin Oncol       Date:  1990-07       Impact factor: 44.544

View more
  1 in total

1.  [Cutaneous lesions due to inhibition of epidermal growth factor receptor].

Authors:  E Bierhoff; H W Seifert; T Dirschka
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.